$6.68
0.30% today
Nasdaq, Apr 02, 08:53 pm CET
ISIN
IL0010941198
Symbol
KMDA
Sector
Industry

Kamada Ltd Stock price

$6.70
+0.10 1.50% 1M
+1.61 31.53% 6M
+0.78 13.17% YTD
+1.25 22.85% 1Y
+1.31 24.40% 3Y
+1.48 28.34% 5Y
+2.26 50.81% 10Y
Nasdaq, Closing price Tue, Apr 01 2025
+0.09 1.36%
ISIN
IL0010941198
Symbol
KMDA
Sector
Industry

Key metrics

Market capitalization $385.28m
Enterprise Value $317.90m
P/E (TTM) P/E ratio 26.63
EV/FCF (TTM) EV/FCF 8.63
EV/Sales (TTM) EV/Sales 1.98
P/S ratio (TTM) P/S ratio 2.39
P/B ratio (TTM) P/B ratio 1.48
Revenue growth (TTM) Revenue growth 12.93%
Revenue (TTM) Revenue $160.95m
EBIT (operating result TTM) EBIT $20.65m
Free Cash Flow (TTM) Free Cash Flow $36.85m
Cash position $78.44m
EPS (TTM) EPS $0.25
P/E forward 24.36
P/S forward 2.14
EV/Sales forward 1.77
Short interest 0.18%
Show more

Is Kamada Ltd a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.

Kamada Ltd Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a Kamada Ltd forecast:

3x Buy
100%

Analyst Opinions

3 Analysts have issued a Kamada Ltd forecast:

Buy
100%

Financial data from Kamada Ltd

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
161 161
13% 13%
100%
- Direct Costs 91 91
5% 5%
57%
70 70
26% 26%
43%
- Selling and Administrative Expenses 20 20
14% 14%
13%
- Research and Development Expense 15 15
9% 9%
9%
34 34
45% 45%
21%
- Depreciation and Amortization 14 14
9% 9%
9%
EBIT (Operating Income) EBIT 21 21
88% 88%
13%
Net Profit 14 14
75% 75%
9%

In millions USD.

Don't miss a Thing! We will send you all news about Kamada Ltd directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Kamada Ltd Stock News

Neutral
GlobeNewsWire
14 days ago
REHOVOT, Israel and HOBOKEN, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today announced the expansion of its plasma collection operations with the opening of a third plasma collection cente...
Neutral
Seeking Alpha
28 days ago
Kamada Ltd. (NASDAQ:KMDA ) Q4 2024 Earnings Conference Call March 5, 2025 8:00 AM ET Company Participants Brian Ritchie – LifeSci Advisors Amir London – Chief Executive Officer Chaime Orlev – Chief Financial Officer Conference Call Participants Annabel Samimy – Stifel Anthony Petrone – Mizuho Group James Sidoti – Sidoti & Co. Operator Greetings, and welcome to the Kamada Fourth Quarter and Full...
Neutral
GlobeNewsWire
28 days ago
REHOVOT, Israel, and HOBOKEN, N.J., March 05, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today announced financial results for the three months and year ended December 31, 2024.
More Kamada Ltd News

Company Profile

Kamada Ltd. engages in the development and production of pharmaceutical products. It operates through the Proprietary Products segment and the Distribution segment. The Proprietary Products segment covers the development, manufacture, and sale of plasma-derived protein therapeutics products. The Distribution segment covers the supply of plasma-based products for clinical use. The company was founded by David Tsur and Ralf Hahn on December 13, 1990 and is headquartered in Rehovot, Israel.

Head office Israel
CEO Amir London
Employees 420
Founded 1990
Website www.kamada.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today